You are here: Industry Insights > COVID-19

News List

FDA Provides New Tool to Aid Development, Evaluation of SARS-CoV-2 Tests americanpharmaceuticalreview
June 04, 2020
The U.S. Food and Drug Administration (FDA) took a new step to support the agency’s evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel.
ARCA Announces AB201 Development Program for COVID-19 Associated Coagulopathy americanpharmaceuticalreview
June 04, 2020
ARCA biopharma announced a new development program to evaluate AB201 (rNAPc2), a potent, selective inhibitor of tissue factor (TF), as a potential treatment for COVID-19 associated coagulopathy (CAC) and the related inflammatory response.
Apellis Initiates Study of APL-9 in Patients with Severe COVID-19 americanpharmaceuticalreview
June 04, 2020
Apellis Pharmaceuticals announced the company has initiated a Phase 1/2 clinical study of APL-9, an investigational C3 inhibitor designed for acute interventions ...
COVID-19 convalescent plasma therapy shown to be safe and effective europeanpharmaceuticalreview
June 04, 2020
Scientists reveal 76 percent of critically ill trial participants treated with convalescent plasma are recovering, with almost half now discharged from hospital.
Global regulatory authorities COVID-19 policy and regulations meeting europeanpharmaceuticalreview
June 04, 2020
Global pharma regulators met to discuss measures to ensure supply continuity, flexible regulatory policies and their expectations for COVID-19 clinical trials.
Novavax Selects AGC Biologics to Manufacture Novel COVID-19 Vax contractpharma
June 04, 2020
To provide large-scale GMP production of Matrix-M, the adjuvant component of Novavax’ coronavirus vaccine candidate, NVX-CoV2373.
FSD Pharma Gets Go Ahead for Phase IIa COVID-19 Trial contractpharma
June 04, 2020
To evaluate FSD-201 to treat COVID-19; anti-inflammatory properties aim to avoid the cytokine storm.
Octapharma Extends Funding for COVID-19 Study contractpharma
June 04, 2020
Study evaluating using IVIG as investigational coronavirus treatment for adults experiencing respiratory failure.
3D Printing in Healthcare: Healthcare Trends pharmaceutical-technology
June 04, 2020
In healthcare, 3D bioprinting is used to create living human cells or tissue for use in regenerative medicine and tissue engineering. Organovo and EnvisionTEC are the pioneers of this technology.
Syngene ties up with HiMedia Laboratories to manufacture ELISA test kits for COVID-19 expresspharma
June 04, 2020
Syngene International, an integrated research and development services company, has entered into collaboration with HiMedia Laboratories for over 45 years, to manufacture and distribute its ELISA kits.